AbbVie Bid for Biotech Could Expand with Experimental Drug
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Safest stablecoins in 2026 balance resilience, reserve quality, and regulatory alignment. This primer outlines evaluation criteria.
15,169 articlesAbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Tired of chasing tenants and fixing leaky roofs? You can build a low-effort real estate portfolio that grows over tim...
Bitwise Asset Management will embed crypto model portfolios into Parrot Finance's retail investing app, marking a shi...
Fomo has closed a $75 million Series B round led by Index Ventures, pushing the company’s valuation to $550 million a...
Public backlash to data centers has spread beyond host towns, threatening timelines and budgets as tech companies dea...
A new nonprofit research lab launched by five former Ethereum Foundation researchers aims to make Ethereum the settle...
As the World Cup turns Atlanta into a spending laboratory, locals and visitors face a stark contrast: bargain bites n...
The centenarian economist who invented fed’s magic trick dies at 100. His successor now weighs reviving the policy pl...
Whether you’re entering the field or leveling up, the right resources make all the difference. This guide maps the be...
The MBA reports a 1.0% weekly rise in mortgage applications, driven by refinancing activity as rates paused near 6.6%...
Bitcoin crashed below $60k as selling pressure intensified and on-chain activity signaled coins moving toward exchang...
The FTSE Russell semi-annual rebalancing will drive heavy trading as index funds realign weights. Markets brace for v...